Methods for treating newly diagnosed multiple myeloma 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione in combination with dexamethasone | Patent Number 09101622

US 09101622 B2
Application Number14482745
Publication NumberUS 20140377293 A1
Pendency11 months, 5 days
Filled DateSep 10, 2014
Priority DateMay 17, 2002
Publication DateDec 25, 2014
Expiration DateMay 17, 2022
Inventor/ApplicantsJerome B. Zeldis
ExaminesSIMMONS, CHRIS E
Art Unit1629
Technology Center1600
Assignments
Celgene
Current
CelgeneBristol Myers Squibb
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.